Yes, most people can live a normal, healthy life after a pulmonary embolism (PE) with prompt treatment, but recovery involves taking blood thinners, managing underlying causes, and addressing potential emotional impacts like anxiety, with some facing long-term issues like fatigue or breathlessness. Full recovery varies, but timely care significantly improves outcomes, often allowing a return to daily routines, though some adapt to a "more vulnerable identity".
While a pulmonary embolism can be life-threatening, most patients survive and need to learn how to live with the risk of recurrence. Your healthcare provider may prescribe anticoagulants, or blood thinners, which may be needed for as little as three months but can be required for the remainder of a patient's life.
Several factors shape your long-term survival after DVT. Studies reveal 85.4% of DVT patients survive past the first year. Your age, body mass index, cancer status, heart failure, and chronic lung disease can all play a role in determining outcomes.
Without treatment, a pulmonary embolism is a very serious condition that can lead to permanent illness or death.
Symptoms typically improve within a few days of starting the anticoagulant. Most patients with DVT or PE recover completely within several weeks to months without significant complications or long-term adverse effects.
previous DVT or PE is one of the biggest risk factors for having another one. And after you complete your treatment and stop taking a blood thinner, your risk of having another blood clot goes up over time. have a 30% chance of having another DVT or PE. And after ten years, that chance grows to 40%.
It is common to have chest pain, breathlessness and fatigue for weeks or even months after a PE. Recovery from PE varies, and it can take many months to return to your previous level of fitness. Sometimes symptoms do not improve over time and further tests may be needed to help work out why.
Abstract. The 60/60 sign in 2D transthoracic echocardiography (TTE) - a combination of pulmonary acceleration time (PAT) less than 60 milliseconds and tricuspid regurgitation (TR) jet gradient of less than 60 mmHg - has been found to be specific for the diagnosis of pulmonary embolism (PE).
Pulmonary embolism (PE) survival rates vary significantly, but timely treatment drastically improves outcomes; around 30% of untreated patients die, while with prompt diagnosis and care, mortality drops dramatically, with some sources citing overall mortality as low as 1-3% for treated cases, though risk depends heavily on the clot's size, patient's overall health, and presence of shock. High-risk PEs (massive) have much higher death rates, potentially 44% or more, whereas low-risk PEs have much lower rates.
According to rehabilitation physician assessment, patients with PE may benefit from increasing their breathing muscle training or exercising with a breathing training device, improving breathing endurance and relieving dyspnea symptoms (42,43).
Recent findings: The death rate after pulmonary embolism is less than 5% during 3-6 months of anticoagulant treatment, provided that the patient is hemodynamically stable and free of major underlying disease. The rate of recurrent thromboembolism is less than 5% on anticoagulant therapy, reaching 30% after 10 years.
Daily Physical Activity
If you regularly remain inactive at a desk for many hours a day, NYU Langone doctors advise you to stand frequently and stretch, take occasional walking breaks, and flex and move your legs and feet while seated. These small steps increase and promote healthy blood flow.
In a Kaplan‐Meier analysis, patients who were treated with warfarin had a mean life expectancy of 52.0 months, whereas those who were not treated with warfarin had a corresponding life expectancy of 38.2 months (Δ = 13.8 months, p < 0.001) (fig 1).
Pulmonary embolism is caused by a blocked artery in the lungs. The most common cause of such a blockage is a blood clot that forms in a deep vein in the leg and travels to the lungs, where it gets lodged in a smaller lung artery.
Patients with pulmonary embolism report fatigue, anxiety and bodily hypervigilance. Patients lack advice from health professionals regarding their pulmonary embolism. Patients find it hard to stay physically active following a pulmonary embolism.
Treating a pulmonary embolism
If tests confirm you have a pulmonary embolism, you'll continue with anticoagulant injections for at least 5 days. You'll also need to take anticoagulant tablets for at least 3 months. You should make a full recovery from a pulmonary embolism if it's spotted and treated early.
The clots happen to some 900,000 people every year in the United States, but most occur in people ages 60 years or older. “Pulmonary embolisms are unusual events in people at a young age,” said Dr. Todd Bull, a pulmonologist and director of the UCHealth Pulmonary Vascular Disease Clinic.
Lung Damage: Pulmonary embolism and CTEPH can lead to long-term damage to the lung tissue, reducing its ability to deliver oxygen to the body. Anxiety and Depression: The emotional toll of living with a serious lung condition can lead to feelings of anxiety, depression and stress, affecting overall well-being.
These symptoms should improve over time, and exercise often helps. Walking and exercise are safe to do, but be sure to listen to your body to avoid overexertion. If you are new to physical activity or just want to ease back into a routine after having a PE or DVT, we suggest starting with a beginner walking routine.
PE is a high-risk medical emergency that is associated with an increased risk of early mortality, with sudden death occurring in 25% of patients. The long-term presence of this condition can result in thromboembolic pulmonary hypertension.
massive PE is defined as acute PE with obstructive shock or SBP <90 mmHg. submassive PE is acute PE without systemic hypotension (SBP ≥90 mm Hg) but with either RV dysfunction or myocardial necrosis. those with none of the above severe features are non-massive or low risk PEs.
Seven common red-flag warning signs of a PE include: Sudden shortness of breath. Sharp chest pain when inhaling. Rapid breathing or wheezing.
Flying with a pulmonary embolism is extremely dangerous and can be fatal. The condition significantly impairs lung function, rendering air travel extremely risky due to the reduced oxygen levels caused by the drop in air pressure at higher altitudes.
Yes. Medicines that are commonly called blood thinners greatly decrease your risk of blood clotting. But they don't prevent blood clots completely.